このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
SpringWorks Therapeutics マネジメント
マネジ メント 基準チェック /24
SpringWorks Therapeutics'の CEO はSaqib Islamで、 Jul2018年に任命され、 の在任期間は 5.92年です。 の年間総報酬は$ 18.35Mで、 4%給与と96%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の1%を直接所有しており、その価値は$ 28.61M 。経営陣と取締役会の平均在任期間はそれぞれ4年と5.4年です。
主要情報
Saqib Islam
最高経営責任者
US$18.4m
報酬総額
| CEO給与比率 | 4.0% |
| CEO在任期間 | 5.9yrs |
| CEOの所有権 | 1.0% |
| 経営陣の平均在職期間 | 4yrs |
| 取締役会の平均在任期間 | 5.4yrs |
経営陣の近況
Recent updates
Need To Know: Analysts Are Much More Bullish On SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Revenues
May 11
We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth
May 03SpringWorks Therapeutics: Newly Commercial Stage, Fully Valued Biotech Means Steer Clear
Apr 25SpringWorks Therapeutics: Multiple Opportunities, But No Sure-Fire Winners
Apr 19We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth
Sep 20We're Not Very Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Rate
Jun 07We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth
Feb 22Here's Why We're Not Too Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation
Nov 09SpringWorks drops 21% as Allogene drops lead asset in combination study
Aug 10SpringWorks Therapeutics GAAP EPS of -$1.41 misses by $0.15
Aug 04Sizing Up SpringWorks Therapeutics
Jul 20Will SpringWorks Therapeutics (NASDAQ:SWTX) Spend Its Cash Wisely?
Jun 06SpringWorks Therapeutics: Rating Buy Ahead Of Mid-Year Data Releases
May 02Companies Like SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Invest In Growth
Dec 30SpringWorks Is A Biotech To Watch With Several Partnerships And Solid Drug Pipeline
Dec 14SpringWorks Therapeutics (NASDAQ:SWTX) Is In A Strong Position To Grow Its Business
Sep 15SpringWorks shows durable effect for neurofibroma therapy with long-term data
Jun 15SpringWorks teams up with Seagen to evaluate nirogacestat combo in multiple myeloma
Jun 07We're Interested To See How SpringWorks Therapeutics (NASDAQ:SWTX) Uses Its Cash Hoard To Grow
May 31SpringWorks Therapeutics EPS misses by $0.11
May 06SpringWorks Therapeutics announces C-level promotions
Dec 15CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$339m |
| Dec 31 2023 | US$18m | US$725k | -US$325m |
| Sep 30 2023 | n/a | n/a | -US$305m |
| Jun 30 2023 | n/a | n/a | -US$298m |
| Mar 31 2023 | n/a | n/a | -US$289m |
| Dec 31 2022 | US$15m | US$680k | -US$277m |
| Sep 30 2022 | n/a | n/a | -US$259m |
| Jun 30 2022 | n/a | n/a | -US$228m |
| Mar 31 2022 | n/a | n/a | -US$206m |
| Dec 31 2021 | US$18m | US$590k | -US$174m |
| Sep 30 2021 | n/a | n/a | -US$107m |
| Jun 30 2021 | n/a | n/a | -US$87m |
| Mar 31 2021 | n/a | n/a | -US$60m |
| Dec 31 2020 | US$8m | US$541k | -US$46m |
| Sep 30 2020 | n/a | n/a | -US$73m |
| Jun 30 2020 | n/a | n/a | -US$68m |
| Mar 31 2020 | n/a | n/a | -US$62m |
| Dec 31 2019 | US$3m | US$480k | -US$51m |
| Sep 30 2019 | n/a | n/a | -US$41m |
| Jun 30 2019 | n/a | n/a | -US$29m |
| Mar 31 2019 | n/a | n/a | -US$18m |
| Dec 31 2018 | US$2m | US$407k | -US$18m |
報酬と市場: Saqibの 総報酬 ($USD 18.35M ) は、 US市場 ($USD 6.82M ) の同規模の企業の平均を上回っています。
報酬と収益: Saqibの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Saqib Islam (54 yo)
5.9yrs
在職期間
US$18,351,489
報酬
Mr. Saqib Islam, J.D. has been Chief Executive Officer and Director at SpringWorks Therapeutics, Inc. since August 2018. He serves as an Independent Director of Passage Bio, Inc. since March 2019. Mr. Isla...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Director | 5.9yrs | US$18.35m | 1% $ 28.6m | |
| Chief Financial Officer | 4.8yrs | US$3.74m | 0.025% $ 720.4k | |
| Chief Operating Officer | 3.4yrs | US$6.64m | 0.24% $ 6.8m | |
| Chief Medical Officer | 2.9yrs | US$4.31m | 0.032% $ 915.6k | |
| Chief Accounting Officer | 4.3yrs | データなし | 0.0083% $ 237.5k | |
| Chief Scientific Officer | less than a year | データなし | データなし | |
| Vice President of Communications & Investor Relations | 6.4yrs | データなし | データなし | |
| General Counsel & Secretary | 4.4yrs | US$2.83m | 0.018% $ 525.5k | |
| Chief People Officer | 3.8yrs | US$2.52m | 0.0065% $ 186.4k | |
| Chief Commercial Officer | 3.3yrs | US$4.94m | 0.014% $ 395.6k |
4.0yrs
平均在職期間
56yo
平均年齢
経験豊富な経営陣: SWTXの経営陣は 経験豊富 であると考えられます ( 4年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Director | 5.9yrs | US$18.35m | 1% $ 28.6m | |
| Independent Director | 4.8yrs | US$520.14k | 0.014% $ 407.6k | |
| Independent Chairman of the Board | 8.4yrs | US$545.14k | 0.41% $ 11.6m | |
| Independent Director | 6.8yrs | US$508.45k | 0.014% $ 407.6k | |
| Independent Director | 1.9yrs | US$507.64k | 0.011% $ 308.5k | |
| Independent Director | 4.1yrs | US$520.14k | 0% $ 0 |
5.4yrs
平均在職期間
66yo
平均年齢
経験豊富なボード: SWTXの 取締役会 は 経験豊富 であると考えられます ( 5.4年の平均在任期間)。